Table of Contents
ISRN Pharmacology
Volume 2014 (2014), Article ID 943523, 6 pages
http://dx.doi.org/10.1155/2014/943523
Research Article

Antioxidant Effects of Bovine Lactoferrin on Dexamethasone-Induced Hypertension in Rat

Department of Pharmacology and Toxicology and Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran

Received 8 September 2013; Accepted 19 November 2013; Published 22 January 2014

Academic Editors: C. R. Triggle, S. Tsuruoka, and M. van den Buuse

Copyright © 2014 Leila Safaeian and Hadi Zabolian. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. L. H. Ong and J. A. Whitworth, “How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids,” Endocrinology and Metabolism Clinics of North America, vol. 40, no. 2, pp. 393–407, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. B. R. Walker, R. Best, C. H. L. Shackleton, P. L. Padfield, and C. R. W. Edwards, “Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension,” Hypertension, vol. 27, no. 2, pp. 190–196, 1996. View at Google Scholar · View at Scopus
  3. T. Iuchi, M. Akaike, T. Mitsui et al., “Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction,” Circulation Research, vol. 92, no. 1, pp. 81–87, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Rajashree and R. Puvanakrishnan, “Dexamethasone induced alterations in enzymatic and nonenzymatic antioxidant status in heart and kidney of rats,” Molecular and Cellular Biochemistry, vol. 181, no. 1-2, pp. 77–85, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Pacher, J. S. Beckman, and L. Liaudet, “Nitric oxide and peroxynitrite in health and disease,” Physiological Reviews, vol. 87, no. 1, pp. 315–424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Zhang, K. D. Croft, T. A. Mori, C. G. Schyvens, K. U. S. McKenzie, and J. A. Whitworth, “The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat,” American Journal of Hypertension, vol. 17, no. 3, pp. 260–265, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. S. S. Bachhav, S. D. Patil, M. S. Bhutada, and S. J. Surana, “Oleanolic acid prevents glucocorticoid-induced hypertension in rats,” Phytotherapy Research, vol. 25, no. 10, pp. 1435–1439, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. C. K. Mondo, W.-S. Yang, N. Zhang, and T.-G. Huang, “Anti-oxidant effects of atorvastatin in dexamethasone-induced hypertension in the rat,” Clinical and Experimental Pharmacology and Physiology, vol. 33, no. 11, pp. 1029–1034, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Tsuchiya, T. Takeuchi, K.-I. Hayashida, H. Shimizu, K. Ando, and E. Harada, “Milk-derived lactoferrin may block tolerance to morphine analgesia,” Brain Research, vol. 1068, no. 1, pp. 102–108, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Fillebeen, L. Descamps, M.-P. Dehouck et al., “Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier,” The Journal of Biological Chemistry, vol. 274, no. 11, pp. 7011–7017, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. J. K. Actor, S.-A. Hwang, and M. L. Kruzel, “Lactoferrin as a natural immune modulator,” Current Pharmaceutical Design, vol. 15, no. 17, pp. 1956–1973, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Baveye, E. Elass, J. Mazurier, G. Spik, and D. Legrand, “Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process,” Clinical Chemistry and Laboratory Medicine, vol. 37, no. 3, pp. 281–286, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. S. A. González-Chávez, S. Arévalo-Gallegos, and Q. Rascón-Cruz, “Lactoferrin: structure, function and applications,” International Journal of Antimicrobial Agents, vol. 33, no. 4, pp. 301.e1–301.e8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. M. Mulder, P. A. Connellan, C. J. Oliver, C. A. Morris, and L. M. Stevenson, “Bovine lactoferrin supplementation supports immune and antioxidant status in healthy human males,” Nutrition Research, vol. 28, no. 9, pp. 583–589, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Maneva, B. Taleva, and L. Maneva, “Lactoferrin-protector against oxidative stress and regulator of glycolysis in human erythrocytes,” Zeitschrift fur Naturforschung C, vol. 58, no. 3-4, pp. 256–262, 2003. View at Google Scholar · View at Scopus
  16. M. S. Cohen, J. Mao, G. T. Rasmussen, J. S. Serody, and B. E. Britigan, “Interaction of lactoferrin and lipopolysaccharide (LPS): effects on the antioxidant property of lactoferrin and the ability of LPS to prime human neutrophils for enhanced superoxide formation,” Journal of Infectious Diseases, vol. 166, no. 6, pp. 1375–1378, 1992. View at Google Scholar · View at Scopus
  17. P. Ruiz-Giménez, A. Ibáñez, J. B. Salom et al., “Antihypertensive properties of lactoferricin B-derived peptides,” Journal of Agricultural and Food Chemistry, vol. 58, no. 11, pp. 6721–6727, 2010. View at Google Scholar
  18. P. Ruiz-Giménez, J. B. Salom, J. F. Marcos et al., “Antihypertensive effect of a bovine lactoferrin pepsin hydrolysate: identification of novel active peptides,” Food Chemistry, vol. 131, no. 1, pp. 266–273, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. K.-I. Hayashida, T. Takeuchi, T. Ozaki et al., “Bovine lactoferrin has a nitric oxide-dependent hypotensive effect in rats,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 286, no. 2, pp. R359–R365, 2004. View at Google Scholar · View at Scopus
  20. P. Ruiz-Giménez, M. C. Burguete, M. Castelló-Ruiz et al., “Bovine lactoferrin pepsin hydrolysate exerts inhibitory effect on angiotensin I-converting enzyme-dependent vasoconstriction,” International Dairy Journal, vol. 17, no. 10, pp. 1212–1215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Fernández-Musoles, J. J. López-Díez, G. Torregrosa et al., “Lactoferricin B-derived peptides with inhibitory effects on ECE-dependent vasoconstriction,” Peptides, vol. 31, no. 10, pp. 1926–1933, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Zhang, J. H. Y. Wu, J. J. Vickers et al., “The role of 20-hydroxyeicosatetraenoic acid in adrenocorticotrophic hormone and dexamethasone-induced hypertension,” Journal of Hypertension, vol. 27, no. 8, pp. 1609–1616, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. S. L. H. Ong, J. J. Vickers, Y. Zhang, K. U. S. McKenzie, C. E. Walsh, and J. A. Whitworth, “Role of xanthine oxidase in dexamethasone-induced hypertension in rats,” Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 5-6, pp. 517–519, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. S. P. Wolff, “Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides,” Methods in Enzymology, vol. 233, pp. 182–189, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Thaipong, U. Boonprakob, K. Crosby, L. Cisneros-Zevallos, and D. Hawkins Byrne, “Comparison of ABTS, DPPH, FRAP, and ORAC assays for estimating antioxidant activity from guava fruit extracts,” Journal of Food Composition and Analysis, vol. 19, no. 6-7, pp. 669–675, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S. L. H. Ong, Y. Zhang, and J. A. Whitworth, “Mechanisms of dexamethasone-induced hypertension,” Current Hypertension Reviews, vol. 5, no. 1, pp. 61–74, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Pirpiris, K. Sudhir, S. Yeung, G. Jennings, and J. A. Whitworth, “Pressor responsiveness in corticosteroid-induced hypertension in humans,” Hypertension, vol. 19, no. 6, pp. 567–574, 1992. View at Google Scholar · View at Scopus
  28. J. A. Whitworth, C. G. Schyvens, Y. Zhang, M. C. Andrews, G. J. Mangos, and J. J. Kelly, “The nitric oxide system in glucocorticoid-induced hypertension,” Journal of Hypertension, vol. 20, no. 6, pp. 1035–1043, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Hu, Y. Zhang, P. S. Lim et al., “Apocynin but not L-arginine prevents and reverses dexamethasone-induced hypertension in the rat,” American Journal of Hypertension, vol. 19, no. 4, pp. 413–418, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Pihlanto-Leppälä, P. Koskinen, K. Phlola, T. Tupasela, and H. Korhonen, “Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides,” Journal of Dairy Research, vol. 67, no. 1, pp. 53–64, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Ikeda, S. Tajima, Y. Izawa-Ishizawa et al., “Bovine milk-derived lactoferrin exerts proangiogenic effects in an Src-Akt-eNOS-dependent manner in response to ischemia,” Journal of Cardiovascular Pharmacology, vol. 61, no. 5, pp. 423–429, 2013. View at Google Scholar
  32. P. Mladenka, V. Semecky, Z. Bobrovova et al., “The effects of lactoferrin in a rat model of catecholamine cardiotoxicity,” Biometals, vol. 22, no. 2, pp. 353–361, 2009. View at Google Scholar
  33. A. Lawen and J. R. Darius, “Lane mammalian iron homeostasis in health and disease: uptake, storage, transport, and molecular mechanisms of action,” Antioxidants & Redox Signaling, vol. 18, no. 18, pp. 2473–2507, 2013. View at Google Scholar
  34. H. Wakabayashi, M. Kurokawa, K. Shin, S. Teraguchi, Y. Tamura, and K. Shiraki, “Oral lactoferrin prevents body weight loss and increases cytokine responses during herpes simplex virus type 1 infection of mice,” Bioscience, Biotechnology and Biochemistry, vol. 68, no. 3, pp. 537–544, 2004. View at Publisher · View at Google Scholar · View at Scopus